Florence Jaguga1, Sarah Kanana Kiburi2, Eunice Temet3, Julius Barasa4, Serah Karanja5, Lizz Kinyua6, Edith Kamaru Kwobah1. 1. Department of Mental Health, Moi Teaching & Referral Hospital, Eldoret, Kenya. 2. Department of Mental Health, Mbagathi Hospital, Nairobi, Kenya. 3. Department of Mental Health & Behavioral Sciences, Moi University School of Medicine, Eldoret, Kenya. 4. Population Health, Academic Model Providing Access to Healthcare, Eldoret, Kenya. 5. Department of Mental Health, Gilgil Sub-County Hospital, Gilgil, Kenya. 6. Intensive Care Unit, Aga Khan University Hospital, Nairobi, Kenya.
Abstract
OBJECTIVES: The burden of substance use in Kenya is significant. The objective of this study was to systematically summarize existing literature on substance use in Kenya, identify research gaps, and provide directions for future research. METHODS: This systematic review was conducted in line with the PRISMA guidelines. We conducted a search of 5 bibliographic databases (PubMed, PsychINFO, Web of Science, Cumulative Index of Nursing and Allied Professionals (CINAHL) and Cochrane Library) from inception until 20 August 2020. In addition, we searched all the volumes of the official journal of the National Authority for the Campaign Against Alcohol & Drug Abuse (the African Journal of Alcohol and Drug Abuse). The results of eligible studies have been summarized descriptively and organized by three broad categories including: studies evaluating the epidemiology of substance use, studies evaluating interventions and programs, and qualitative studies exploring various themes on substance use other than interventions. The quality of the included studies was assessed with the Quality Assessment Tool for Studies with Diverse Designs. RESULTS: Of the 185 studies that were eligible for inclusion, 144 investigated the epidemiology of substance use, 23 qualitatively explored various substance use related themes, and 18 evaluated substance use interventions and programs. Key evidence gaps emerged. Few studies had explored the epidemiology of hallucinogen, prescription medication, ecstasy, injecting drug use, and emerging substance use. Vulnerable populations such as pregnant women, and persons with physical disability had been under-represented within the epidemiological and qualitative work. No intervention study had been conducted among children and adolescents. Most interventions had focused on alcohol to the exclusion of other prevalent substances such as tobacco and cannabis. Little had been done to evaluate digital and population-level interventions. CONCLUSION: The results of this systematic review provide important directions for future substance use research in Kenya. SYSTEMATIC REVIEW REGISTRATION: PROSPERO: CRD42020203717.
OBJECTIVES: The burden of substance use in Kenya is significant. The objective of this study was to systematically summarize existing literature on substance use in Kenya, identify research gaps, and provide directions for future research. METHODS: This systematic review was conducted in line with the PRISMA guidelines. We conducted a search of 5 bibliographic databases (PubMed, PsychINFO, Web of Science, Cumulative Index of Nursing and Allied Professionals (CINAHL) and Cochrane Library) from inception until 20 August 2020. In addition, we searched all the volumes of the official journal of the National Authority for the Campaign Against Alcohol & Drug Abuse (the African Journal of Alcohol and Drug Abuse). The results of eligible studies have been summarized descriptively and organized by three broad categories including: studies evaluating the epidemiology of substance use, studies evaluating interventions and programs, and qualitative studies exploring various themes on substance use other than interventions. The quality of the included studies was assessed with the Quality Assessment Tool for Studies with Diverse Designs. RESULTS: Of the 185 studies that were eligible for inclusion, 144 investigated the epidemiology of substance use, 23 qualitatively explored various substance use related themes, and 18 evaluated substance use interventions and programs. Key evidence gaps emerged. Few studies had explored the epidemiology of hallucinogen, prescription medication, ecstasy, injecting drug use, and emerging substance use. Vulnerable populations such as pregnant women, and persons with physical disability had been under-represented within the epidemiological and qualitative work. No intervention study had been conducted among children and adolescents. Most interventions had focused on alcohol to the exclusion of other prevalent substances such as tobacco and cannabis. Little had been done to evaluate digital and population-level interventions. CONCLUSION: The results of this systematic review provide important directions for future substance use research in Kenya. SYSTEMATIC REVIEW REGISTRATION: PROSPERO: CRD42020203717.
Authors: Aggrey G Mokaya; Victoria Mutiso; Abednego Musau; Albert Tele; Yeri Kombe; Zipporah Ng'ang'a; Erica Frank; David M Ndetei; Veronic Clair Journal: J Psychoactive Drugs Date: 2016-08-02
Authors: Shukri F Mohamed; Martin K Mutua; Richard Wamai; Frederick Wekesah; Tilahun Haregu; Pamela Juma; Loise Nyanjau; Catherine Kyobutungi; Elijah Ogola Journal: BMC Public Health Date: 2018-11-07 Impact factor: 3.295
Authors: Frederick M Wekesah; Loise Nyanjau; Joseph Kibachio; Martin K Mutua; Shukri F Mohamed; Diederick E Grobbee; Kerstin Klipstein-Grobusch; Christine Ngaruiya; Tilahun N Haregu; Gershim Asiki; Catherine K Kyobutungi Journal: BMC Public Health Date: 2018-11-07 Impact factor: 3.295
Authors: Andrew M Secor; Elizabeth Wahome; Murugi Micheni; Deepa Rao; Jane M Simoni; Eduard J Sanders; Susan M Graham Journal: AIDS Date: 2015-12 Impact factor: 4.177
Authors: Valentine Budambula; Charles Matoka; James Ouma; Aabid A Ahmed; Michael F Otieno; Tom Were Journal: BMC Public Health Date: 2018-01-30 Impact factor: 3.295